TD Cowen Maintains Buy on DexCom, Lowers Price Target to $75

Benzinga Newsdesk www.benzinga.com Negative 56.4%

Neg 56.4% Neu 0% Pos 0%

TD Cowen analyst Joshua Jennings maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $84 to $75.

Comments

No comments yet. Be the first!